Hanover biotechnology firm Processa Pharmaceuticals Inc. is raising up to $8 million in new equity funding, according to a recent filing with the U.S. Securities and Exchange Commission. The publicly traded drug development company, previously known as Heatwurx Inc., raised $2.6 million in debt financing last year, according to SEC documents. More than half of the goal in the most recent round has already been raised, from more than 30 investors. In the filing, Processa (OTC: PCSA) notes that…
from https://www.bizjournals.com/baltimore/news/2018/05/22/hanover-biotech-processa-pharma-raising-8-million.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/174149988217
No comments:
Post a Comment